# Andapharm, LLC – FDA Inspection, Jul 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/andapharm-llc/df2941b0-2e30-4a14-ac3b-8191f03554a9
Source feed: FDA_Inspections

> FDA inspection 1059714 of Andapharm, LLC, July 18, 2018. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059714
- Company Name: Andapharm, LLC
- Inspection Date: 2018-07-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 961715 - 2016-02-26](https://www.keypedia.com/records/fda_inspections/andapharm-llc/e7fe3687-2e68-4da7-9ad7-8a3d9a783308)
- [FDA Inspection 764765 - 2012-02-07](https://www.keypedia.com/records/fda_inspections/andapharm-llc/89f52d14-491f-42ee-a275-4b2d73793cbd)
- FDA Inspection 602314 - 2009-08-07

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/gideon-n-esuzor/78dae9f4-77e9-469b-982d-2d4a42cc641f)
- [FDA Associated Person](https://www.keypedia.com/people/tajah-l-blackburn/27b25d9d-3186-4b3a-a511-2f693d3c889a)

Company: https://www.keypedia.com/companies/andapharm-llc/62711f7a-0996-4623-93e4-87351349e6c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
